Literature DB >> 24033437

Prevalence and quality of clinical pathways in Swedish intensive care units: a national survey.

Petronella Bjurling-Sjöberg1, Inger Jansson, Barbro Wadensten, Gabriella Engström, Ulrika Pöder.   

Abstract

RATIONALE, AIMS AND
OBJECTIVES: To identify the prevalence of clinical pathways (CPs) in Swedish intensive care units (ICUs) and to explore the quality, content and evidence base of the documents.
METHODS: A descriptive and explorative survey of all Swedish ICUs (N84) and a review of submitted examples of CPs (n12) were conducted.
RESULTS: CPs were in use at 20% of the Swedish ICUs. There was a significant geographic variation but no relationship between the use of CPs and category of hospital, type of ICU, size of ICU or type of health record applied. In total, 56 CPs were reported within a range of scopes and extensions. The content of the ICUs' CPs, as well as the degree to which they were interprofessional, evidence based, and renewed varied.
CONCLUSIONS: Progress has been made in relation to CPs in recent years, but there is potential for further improvements. None of the ICUs had CPs that contained all key characteristics of a high-quality, interprofessional and evidence-based CP identified in the literature. Greater knowledge sharing and cooperation within the field would be beneficial, and further research is needed.
© 2013 John Wiley & Sons, Ltd.

Keywords:  clinical pathways; evidence-based practice; intensive care; organization; professional practice; standardized care plans

Mesh:

Year:  2013        PMID: 24033437     DOI: 10.1111/jep.12078

Source DB:  PubMed          Journal:  J Eval Clin Pract        ISSN: 1356-1294            Impact factor:   2.431


  1 in total

1.  Struggling for a feasible tool - the process of implementing a clinical pathway in intensive care: a grounded theory study.

Authors:  Petronella Bjurling-Sjöberg; Barbro Wadensten; Ulrika Pöder; Inger Jansson; Lena Nordgren
Journal:  BMC Health Serv Res       Date:  2018-11-06       Impact factor: 2.655

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.